Welcome to the our website of the Malaria Vaccine Reserach Group (MV-RG). Our team is dedicated to finding and producing alternative malaria prophylaxis drugs. We are delighted to have you here and excited to share our journey, discoveries, and innovations. 

Parasite resistance to antiparasitic drugs makes innovation in the development of antiparasitic drugs very important. The specific target of this study is to find a formulation that consistently produces products with characteristics that meet the criteria for nanoparticles, and to find the optimal dose for malaria prevention in experimental animals or parasite inhibition. Our long term goal aim is to develop alternative malaria prophylaxis drugs for people who will travel to malaria-endemic areas.